BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1466313)

  • 21. [Prevalence of dyslipidemia among residents aged 18-69 years in Shandong province of China, 2011].
    Zhang J; Tang J; Guo X; Dong J; Ren J; Chen X; Gao C; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Mar; 50(3):230-4. PubMed ID: 26957240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.
    Grundy SM; Vega GL
    Arch Intern Med; 1992 Jan; 152(1):28-34. PubMed ID: 1728925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol.
    Rubins HB; Robins SJ; Iwane MK; Boden WE; Elam MB; Fye CL; Gordon DJ; Schaefer EJ; Schectman G; Wittes JT
    Am J Cardiol; 1993 Jan; 71(1):45-52. PubMed ID: 8420235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
    Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
    Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
    Fruchart JC; Duriez P
    Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertriglyceridemia as a cardiovascular risk factor.
    Austin MA; Hokanson JE; Edwards KL
    Am J Cardiol; 1998 Feb; 81(4A):7B-12B. PubMed ID: 9526807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of triglycerides and HDL cholesterol in hypertriglyceridemia.
    Avogaro P; Ghiselli G; Soldan S; Bittolo Bon G
    Atherosclerosis; 1992 Jan; 92(1):79-86. PubMed ID: 1575823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertriglyceridemia as a possible independent risk factor for stroke.
    Lisak M; Demarin V; Trkanjec Z; Basić-Kes V
    Acta Clin Croat; 2013 Dec; 52(4):458-63. PubMed ID: 24696996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertriglyceridemia and low HDL: therapeutic considerations.
    Larsen ML
    Curr Opin Lipidol; 1994 Feb; 5(1):42-7. PubMed ID: 15559030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High triglyceride, low HDL-cholesterol and risk of coronary heart disease].
    Jeppesen J; Madsbad S
    Ugeskr Laeger; 1996 Nov; 158(48):6896-901. PubMed ID: 8984751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond.
    Austin MA
    Am J Epidemiol; 1989 Feb; 129(2):249-59. PubMed ID: 2643302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertriglyceridemia and low HDL cholesterol in Japanese patients with NIDDM.
    Okubo M; Murase T
    Diabetes; 1996 Jul; 45 Suppl 3():S123-5. PubMed ID: 8674878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Increased triglycerides and/or low HDL cholesterol. A risk factor needing treatment?].
    Steinmetz A
    MMW Fortschr Med; 2002 Aug; 144(31-32):20-3. PubMed ID: 12422724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum triglycerides as a risk factor for atherosclerosis].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 1999 Feb; 143(6):284-7. PubMed ID: 10221081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
    Nordestgaard BG
    Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-HDL cholesterol as a measure of atherosclerotic risk.
    Packard CJ; Saito Y
    J Atheroscler Thromb; 2004; 11(1):6-14. PubMed ID: 15067193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
    Ascaso J; Gonzalez Santos P; Hernandez Mijares A; Mangas Rojas A; Masana L; Millan J; Pallardo LF; Pedro-Botet J; Perez Jimenez F; Pintó X; Plaza I; Rubiés J; Zúñiga M
    Am J Cardiovasc Drugs; 2007; 7(1):39-58. PubMed ID: 17355165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K;
    Atherosclerosis; 2008 Sep; 200(1):135-40. PubMed ID: 18667204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.